Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.580
+0.010 (0.64%)
At close: May 12, 2026, 4:00 PM EDT
1.590
+0.010 (0.63%)
After-hours: May 12, 2026, 6:00 PM EDT
Biomea Fusion Employees
Biomea Fusion had 41 employees as of December 31, 2025. The number of employees decreased by 65 or -61.32% compared to the previous year.
Employees
41
Change
-65
Growth
-61.32%
Revenue / Employee
n/a
Profits / Employee
-$1,096,341
Market Cap
114.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -65 | -61.32% |
| Sep 30, 2025 | 42 | -65 | -60.75% |
| Jun 30, 2025 | 63 | -49 | -43.75% |
| Mar 31, 2025 | 79 | -31 | -28.18% |
| Dec 31, 2024 | 106 | 3 | 2.91% |
| Sep 30, 2024 | 107 | 4 | 3.88% |
| Jun 30, 2024 | 112 | 18 | 19.15% |
| Mar 31, 2024 | 110 | 24 | 27.91% |
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Sep 30, 2023 | 103 | 28 | 37.33% |
| Jun 30, 2023 | 94 | 22 | 30.56% |
| Mar 31, 2023 | 86 | 29 | 50.88% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Sep 30, 2022 | 75 | 28 | 59.57% |
| Jun 30, 2022 | 72 | 52 | 260.00% |
| Mar 31, 2022 | 57 | 37 | 185.00% |
| Dec 31, 2021 | 51 | 39 | 325.00% |
| Sep 30, 2021 | 47 | 35 | 291.67% |
| Jun 30, 2021 | 20 | - | - |
| Mar 31, 2021 | 20 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| Fractyl Health | 100 |
| Rani Therapeutics Holdings | 71 |
| PepGen | 56 |
| Cardiff Oncology | 31 |
| Oncolytics Biotech | 29 |
| Cognition Therapeutics | 14 |
BMEA News
- 3 hours ago - Biomea Fusion to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 23 hours ago - Biomea Fusion reports Q1 EPS (17c), consensus (19c) - TheFly
- 1 day ago - Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 days ago - Biomea Fusion options imply 18.9% move in share price post-earnings - TheFly
- 5 days ago - Biomea Fusion options imply 23.1% move in share price post-earnings - TheFly
- 7 days ago - Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions - GlobeNewsWire
- 7 days ago - Biomea Fusion Transcript: Status update - Transcripts
- 7 days ago - Biomea Fusion initiated with an Outperform at Citizens - TheFly